Pocovi M, Cenarro A, Civeira F, Torralba M A, Perez-Calvo J I, Mozas P, Giraldo P, Giralt M, Myers R H, Cupples L A, Ordovas J M
Department of Biochemistry, Molecular and Cellular Biology, Faculty of Sciences, University of Zaragoza, Spain.
Lancet. 1998 Jun 27;351(9120):1919-23. doi: 10.1016/S0140-6736(97)09490-7.
Gaucher's disease is the most common lysosomal storage disorder, caused by deficiency of glucocerebrosidase resulting from homozygosity for any of several mutations of the glucocerebrosidase gene locus. Affected people have decreased concentrations of LDL cholesterol (LDL-C) and HDL cholesterol (HDL-C). We assessed the association between mutations in the glucocerebrosidase locus and hypo-alpha-lipoproteinaemia.
We studied 258 people from 43 unrelated Spanish families. 57 participants were affected, 137 were non-affected carriers, and 64 were non-carriers. We determined glucocerebrosidase genotypes and measured plasmid lipids, apolipoproteins A-I, B, and E, and leucocyte glucocerebrosidase activity.
The most common glucocerebrosidase mutations were N370S (45%), L444P (23%), and G377S (5%). Deletions and recombinants accounted for another 5%, and point mutations in exons 5, 6, 9, and 10 were present in 12%. Affected participants had lower LDL-C and HDL-C concentrations than non-affected carriers (p<0.001) and non-carriers (p<0.001). HDL-C values were also significantly different between the non-affected carriers and non-carriers. Mutations at this locus may account for as much as 19.5% of the genetic variability in HDL-C in the population studied.
Heterozygosity for these mutations at the glucocerebrosidase locus does not result in clinical expression of Gaucher's disease but can decrease HDL-C concentrations. Given the high frequency of these mutations, the glucocerebrosidase locus might lead to familial low alpha-lipoproteinaemia in up to 2% of the general population and be one of the most common known genetic causes of HDL-C.
戈谢病是最常见的溶酶体贮积症,由葡萄糖脑苷脂酶基因位点的几种突变之一的纯合性导致葡萄糖脑苷脂酶缺乏引起。患者的低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)浓度降低。我们评估了葡萄糖脑苷脂酶基因位点突变与低α脂蛋白血症之间的关联。
我们研究了来自43个不相关西班牙家庭的258人。57名参与者患病,137名是未患病携带者,64名是非携带者。我们确定了葡萄糖脑苷脂酶基因型,并测量了血浆脂质、载脂蛋白A-I、B和E以及白细胞葡萄糖脑苷脂酶活性。
最常见的葡萄糖脑苷脂酶突变是N370S(45%)、L444P(23%)和G377S(5%)。缺失和重组占另外5%,外显子5、6、9和10中的点突变占12%。患病参与者的LDL-C和HDL-C浓度低于未患病携带者(p<0.001)和非携带者(p<0.001)。未患病携带者和非携带者之间的HDL-C值也有显著差异。该基因位点的突变可能占所研究人群中HDL-C遗传变异性的19.5%。
葡萄糖脑苷脂酶基因位点这些突变的杂合性不会导致戈谢病临床症状,但会降低HDL-C浓度。鉴于这些突变的高频率,葡萄糖脑苷脂酶基因位点可能导致高达2%的普通人群出现家族性低α脂蛋白血症,并且是HDL-C最常见的已知遗传原因之一。